Pulmonary Tuberculosis

• CLINICAL_TRIALS research · 2017-04-13
  Clinical Trial Update: Evaluation of 11C-acetate PET Imaging as a Novel Approach to Detecting Pathology in Pulmonary TB [Phase 1]

  A Phase 1 clinical trial evaluating 11C-acetate PET imaging as a novel approach to detect pathology in pulmonary tuberculosis.

• CLINICAL_TRIALS research · 2016-08-03
  Clinical Trial Update: Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance [NA]

  A completed clinical trial from Hospital de Clinicas de Porto Alegre evaluating an educational strategy and oversight approach to managing t…

• CLINICAL_TRIALS research · 2016-05-11
  Clinical Trial Update: Diagnostic Trial to Validate the Use of the E-Nose in Pulmonary TB [NA]

  A clinical trial led by Universidad Central de Venezuela is evaluating the e-Nose device for diagnosing pulmonary tuberculosis; the current …

• CLINICAL_TRIALS research · 2015-06-25
  Clinical Trial Update: 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT [Phase 1, Phase 2]

  Clinical trial update of 68Ga-AlfatideII for differentiating lung cancer from pulmonary tuberculosis using PET/CT in Phase 1/Phase 2 (status…

• CLINICAL_TRIALS research · 2015-06-08
  Clinical Trial Update: Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis [Phase 4]

  Phase 4 clinical trial examining vitamin D as adjunctive therapy for pulmonary tuberculosis; current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2015-01-06
  Clinical Trial Update: Research on New Regimens for Retreatment Pulmonary Tuberculosis [Phase 4]

  This update reports on ongoing Phase 4 research evaluating new treatment regimens for retreatment pulmonary tuberculosis.

• CLINICAL_TRIALS research · 2012-12-27
  Clinical Trial Update: Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment [Phase 4]

  This document provides an update on regimens for reintroducing anti-tuberculosis therapy after hepatitis during TB treatment in a Phase 4 cl…

• CLINICAL_TRIALS research · 2012-08-30
  Clinical Trial Update: The Role of Apoptosis Associated Markers in Pathogenesis of Pulmonary Tuberculosis

  This clinical trial investigates serum apoptosis-associated markers to differentiate active pulmonary tuberculosis from latent tuberculosis …

• CLINICAL_TRIALS research · 2012-06-14
  Clinical Trial Update: Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis

  This clinical trial update assesses how frequently Mycoplasma pneumoniae co-infection occurs in patients with pulmonary tuberculosis and its…

• CLINICAL_TRIALS research · 2012-01-02
  Clinical Trial Update: Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease

  A clinical trial update focuses on diagnostics for intestinal tuberculosis and how to differentiate it from Crohn's disease.

• CLINICAL_TRIALS research · 2011-04-12
  Clinical Trial Update: Pharmacokinetic Study for Anti-tuberculosis Drugs [NA]

  This clinical trial update describes a pharmacokinetic study of anti-tuberculosis drugs for pulmonary tuberculosis. The current status of th…

• CLINICAL_TRIALS research · 2009-02-03
  Clinical Trial Update: Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

  This completed clinical trial examined whether NAT2 and CYP2E1 genetic variants influence the risk of antituberculosis therapy–induced hepat…

• CLINICAL_TRIALS research · 2006-09-13
  Clinical Trial Update: Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary Tuberculosis [Phase 4]

  A multicenter Phase 4 clinical trial is evaluating a fixed-dose combination tablet for the treatment of pulmonary tuberculosis.